---
title: "ATHERSTONE PHARMA LTD — Ownership Dossier"
canonical: https://whiteintel.dev/entity/61290532-dc46-56e5-a6fc-9f2e12ff9ddb
json: https://whiteintel.dev/api/public/dossier/61290532-dc46-56e5-a6fc-9f2e12ff9ddb
identifier: oo:GB-COH-08008790
jurisdiction: GB
risk: Low
source: WhiteIntel corporate-ownership graph
---

# ATHERSTONE PHARMA LTD

**Type:** Company  
**Jurisdiction:** [GB](https://whiteintel.dev/jurisdictions/gb)  
**Identifier:** `oo:GB-COH-08008790`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/61290532-dc46-56e5-a6fc-9f2e12ff9ddb  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/61290532-dc46-56e5-a6fc-9f2e12ff9ddb  

## Ownership & control

### Owners / controllers

- **Doctor Andrew Scott Thomson** (beneficial owner) — https://whiteintel.dev/entity/603061b6-8adc-4940-92d8-70821f983404
- **Atherstone Medical Ltd** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/3949a139-de1a-4c94-b635-1d819cb0d4cb

### UBO chain (walk to the ultimate owner)

A **20-step** ownership/control chain to the ultimate beneficial owner is resolved for this entity. The full cited chain unlocks with a paid API key or a one-off dossier — https://whiteintel.dev/pricing.

## Company profile (live · UK Companies House)

- **Company number:** `08008790`
- **Status:** active
- **Type:** ltd
- **Incorporated:** 2012-03-27
- **Registered office:** 1 Ratcliffe Road, Atherstone, Warwickshire, CV9 1EU
- **SIC:** 86900

### Officers

- MEHTA, Kishan — director · British · appointed 2025-03-07
- SAHOTA, Jeetender Singh — director · British · appointed 2025-03-07
- GODFREY, Andrea Mary, Doctor — director · British · appointed 2012-03-27 · resigned 2025-03-07
- GOODING, Trevor Nigel, Dr — director · British · appointed 2012-03-27 · resigned 2025-03-07
- MAHER, Michael Patrick, Dr — director · British · appointed 2012-03-27 · resigned 2013-03-31
- PURNELL-MULLICK, Samir, Doctor — director · British · appointed 2012-03-27 · resigned 2025-03-07
- SINGH, Bhawna — director · British · appointed 2021-02-17 · resigned 2025-03-07
- THOMSON, Andrew Scott, Doctor — director · British · appointed 2012-03-27 · resigned 2025-03-07
- WESTON, David Andrew, Dr — director · British · appointed 2012-03-27 · resigned 2025-03-07
- WINWARD, John Mcgregor, Dr — director · British · appointed 2012-03-27 · resigned 2025-03-07

### Beneficial owners (Persons with Significant Control)

- Atherstone Medical Ltd — 75–100% shares · corporate PSC · England — since 2025-03-07
- Doctor Andrew Scott Thomson — significant influence or control · individual PSC — ceased 2025-03-07

## Provenance

- companies_house_bulk — https://find-and-update.company-information.service.gov.uk/company/08008790
- OpenOwnership — https://find-and-update.company-information.service.gov.uk/company/08008790

## Get the full, resolved dossier (agent-callable)

The above is the free teaser. The resolved **multi-hop UBO chain**, ownership **%**, full **financial history**, itemised **assets** and the hop-by-hop **exposure path** are the paid depth — callable as tools from your agent:

```bash
npx -y @whiteintel/mcp-server   # then: get_dossier · trace_ownership_path · check_offshore_exposure
```

Or unlock a one-off cited dossier for **ATHERSTONE PHARMA LTD** — https://whiteintel.dev/entity/61290532-dc46-56e5-a6fc-9f2e12ff9ddb · pricing https://whiteintel.dev/pricing.

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **ATHERSTONE PHARMA LTD**. Human view: https://whiteintel.dev/entity/61290532-dc46-56e5-a6fc-9f2e12ff9ddb · Structured JSON: https://whiteintel.dev/api/public/dossier/61290532-dc46-56e5-a6fc-9f2e12ff9ddb._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._